BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
BioCorRx Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.25+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $7.30M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.1500 (−37.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
BioCorRx Inc. grew revenue 10301.1% to $797.24K over fiscal 2025.
Revenue
$797.24K
+10301.1% vs. a year earlier
Operating income
-$4.90M
TTM Q2 2026
EPS, diluted
-$0.15
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $7.30M
- P/E ratio
- –
- Price to sales
- 9.16
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $797.24K
- Net income
- -$3.16M
- EPS, diluted
- -$0.15
- Book value per share
- -$0.42
- Diluted shares
- 29M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$4.90M
Net income
-$3.16M
EPS, diluted
-$0.15
Free cash flow
–
Reported periodTrailing twelve months